SMPD2 and neoplasm: Our findings illustrate that compared to monotherapies, dual blockade combinations encompassing GW4869 (N‐SMase inhibitor) combined with a Tim3‐blocking antibody substantially amplify the tumour lysis capabilities of intratumoral NK cells.3